Reminyl Er (galantamine Hydrobromide) - New Safety Information Regarding The Risk Of Serious Skin Reactions - For Health Professionals

REMINYL ER Recall Summary Reminyl ER (galantamine hydrobromide), a medication used to treat Alzheimer's disease, is being recalled across Canada due to new safety information about the risk of serious skin reactions. The recall applies to all patients currently taking this medication across the country. Health professionals have been notified of this safety concern.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2014-11-18

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/10cb1440-f721-4e73-8ff8-a19c00a35c89